To direct the Administrator of the Federal Aviation Administration to include medications and medical equipment for the emergency treatment of known or suspected opioid overdose in aircraft emergency medical kits, and for other purposes.
Latest action · May 24, 2023 Referred to the Subcommittee on Aviation.
Progress
Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.
- IntroducedMay 23, 2023
- Passed HouseNot reached
- Passed SenateNot reached
- To the PresidentNot reached
- Became lawNot reached
Summary
This bill directs the Federal Aviation Administration (FAA) to require that medications and medical equipment for the emergency treatment of a known or suspected opioid overdose be included in an aircraft emergency medical kit; the FAA must, to the maximum extent possible, follow the guidance of the Aerospace Medical Association.
In a 2019 guidance document to the FAA, the Aerospace Medical Association recommended including an opioid antagonist (e.g., naloxone or Narcan) in an aircraft emergency medical kit.
Cosponsors 20
Members who signed on, in the order they did. Signatures ran from May 23, 2023 to Jul 2, 2024; 2 are original cosponsors, there from the day it was introduced.
| Seat | Cosponsor | Signed on | |
|---|---|---|---|
| D-CO | Brittany Pettersen | Original | May 23, 2023 |
| R-TX | Jake Ellzey | Original | May 23, 2023 |
| D-NH | Ann M. Kuster | Jun 5, 2023 | |
| D-NV | Dina Titus | Jun 5, 2023 | |
| D-DC | Eleanor Holmes Norton | Jun 5, 2023 | |
| D-NY | Paul Tonko | Jun 5, 2023 | |
| D-FL | Sheila Cherfilus-McCormick | Jun 5, 2023 | |
| D-MN | Angie Craig | Jun 6, 2023 | |
| D-CA | Adam B. Schiff | Jun 7, 2023 | |
| D-NJ | Bonnie Watson Coleman | Jun 7, 2023 | |
| D-CA | Ro Khanna | Jun 7, 2023 | |
| D-IL | Eric Sorensen | Jun 16, 2023 | |
| D-AZ | Raúl M. Grijalva | Jun 16, 2023 | |
| D-NC | Wiley Nickel | Jun 16, 2023 | |
| D-TX | Colin Z. Allred | Jul 13, 2023 | |
| R-NE | Don Bacon | Jul 18, 2023 | |
| R-PA | Brian K. Fitzpatrick | Aug 18, 2023 | |
| D-IL | Nikki Budzinski | Oct 11, 2023 | |
| R-NJ | Christopher H. Smith | Apr 12, 2024 | |
| D-RI | Seth Magaziner | Jul 2, 2024 |
Committees 1
Where it was sent and what each committee and subcommittee did with it, in order.
| Chamber | Committee | What it did |
|---|---|---|
| House | Transportation and Infrastructure Committee | Referred May 23, 2023 |
| Aviation Subcommittee | Referred May 24, 2023 |
Actions 3
Everything that happened, newest first.
- May 24, 2023Referred to the Subcommittee on Aviation.
- May 23, 2023Introduced in House
- May 23, 2023Referred to the House Committee on Transportation and Infrastructure.
Research
What has been written about this bill: committee reports, cost estimates, the sponsor’s authority statement, printed hearings and the Congressional Research Service’s work.
Constitutional authority
The sponsor’s statement, as printed in the Congressional Record, vol. 169, no. 87, May 23, 2023, page H2547.
Titles 1
Every title it has carried, official and short, at each stage.
- Official Title as Introduced
- To direct the Administrator of the Federal Aviation Administration to include medications and medical equipment for the emergency treatment of known or suspected opioid overdose in aircraft emergency medical kits, and for other purposes.
Subjects
Assigned by the Library of Congress. Policy area: Transportation and Public Works.
Text 1
Each version as it was printed, newest first.
- May 23, 2023Introduced in House
Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.
